Fig. 6

Immune activation and cell cycle processes were enriched according to CLEC3B expression in lung cancer. Gene set enrichment analysis was performed using the TCGA gene expression profiles of ADC and SCC, and the ʻc5.all.v5.1ʼ gene set was selected to process the analysis. a–e Immune activation processes were enriched in the CLEC3B high expression group of SCC. f–j Cell cycle processes were enriched in the CLEC3B low expression group of ADC. k–o Cell cycle processes were enriched in the CLEC3B low expression group of SCC; NES, normal enrichment score; FDR, false discovery rate